Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Draft Provider-Administered Oncology Drug Policies .

Abraxane, Paclitaxel Albumin-Bound

Adcertis

Trastuzumab:

Herceptin®; Ogivri®; Kanjinti®; Trazimera™; Herzuma®; Ontruzant®

Alimta, Pemfexy, Pemetrexed

print Print Back Back Vectibix® (panitumumab) (Intravenous) Policy Number: VP-90136 Last Review Date:...

Bortezomib

Velcade®; Bortezomib§

print Print Back Back Bevacizumab: Avastin®; Mvasi®; Zirabev™; Alymsys®; Vegzelma™ (Intravenous) Policy...

print Print Back Back Yervoy™ (ipilimumab) (Intravenous) Policy Number: VP-90148 Last Review Date: 12/07/2023...

print Print Back Back Kyprolis® (carfilzomib) (Intravenous) Policy Number: VP-90157 Last Review Date:...

print Print Back Back Gazyva (obinutuzumab) (Intravenous) Policy Number: VP-90184 Last Review Date:...

Sylvant

Keytruda

Opdivo

print Print Back Back Darzalex™ (daratumumab) (Intravenous) Policy Number: VP-90266 Last Review Date:...

Tecentriq® (atezolizumab)

print Print Back Back Bavencio® (avelumab) (Intravenous) Policy Number: VP-90295 Last Review Date: 12/07/2023 ...

print Print Back Back Imfinzi™ (durvalumab) (Intravenous) Policy Number: VP-90301 Last Review Date: 12/07/2023...

print Print Back Back Erbitux® (cetuximab) (Intravenous) Policy Number: VP-9038 Last Review Date: 12/07/2023 ...

print Print Back Back Libtayo® (cemiplimab-rwlc) (Intravenous) Policy Number: VP-90398 Last Review Date:...

print Print Back Back Fulvestrant: Faslodex®; Fulvestrant Ψ (Intramuscular) Policy Number: VP-9043 Last...